555 related articles for article (PubMed ID: 16230590)
1. Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer.
El-Deiry M; Funk GF; Nalwa S; Karnell LH; Smith RB; Buatti JM; Hoffman HT; Clamon GH; Graham SM; Trask DK; Dornfeld KJ; Yao M
Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):879-85. PubMed ID: 16230590
[TBL] [Abstract][Full Text] [Related]
2. Quality of life after treatment for advanced laryngeal and hypopharyngeal cancer.
Major MS; Bumpous JM; Flynn MB; Schill K
Laryngoscope; 2001 Aug; 111(8):1379-82. PubMed ID: 11568572
[TBL] [Abstract][Full Text] [Related]
3. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.
Fung K; Lyden TH; Lee J; Urba SG; Worden F; Eisbruch A; Tsien C; Bradford CR; Chepeha DB; Hogikyan ND; Prince ME; Teknos TN; Wolf GT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1395-9. PubMed ID: 16087298
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma.
Yao M; Karnell LH; Funk GF; Lu H; Dornfeld K; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1354-60. PubMed ID: 17689885
[TBL] [Abstract][Full Text] [Related]
5. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer.
Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF
Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818
[TBL] [Abstract][Full Text] [Related]
6. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiotherapy after transoral laser microsurgery for advanced squamous carcinoma of the head and neck.
Pradier O; Christiansen H; Schmidberger H; Martin A; Jäckel MC; Steiner W; Ambrosch P; Kahler E; Hess CF
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1368-77. PubMed ID: 16169679
[TBL] [Abstract][Full Text] [Related]
8. Quality of life outcomes in laryngeal and oropharyngeal cancer patients after chemoradiation.
Mowry SE; LoTempio MM; Sadeghi A; Wang KH; Wang MB
Otolaryngol Head Neck Surg; 2006 Oct; 135(4):565-70. PubMed ID: 17011418
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in patients with oropharynx carcinomas: assessment after accelerated radiotherapy with or without chemotherapy versus radical surgery and postoperative radiotherapy.
Allal AS; Nicoucar K; Mach N; Dulguerov P
Head Neck; 2003 Oct; 25(10):833-9; discussion 839-40. PubMed ID: 12966507
[TBL] [Abstract][Full Text] [Related]
10. Swallowing-related quality of life after head and neck cancer treatment.
Gillespie MB; Brodsky MB; Day TA; Lee FS; Martin-Harris B
Laryngoscope; 2004 Aug; 114(8):1362-7. PubMed ID: 15280708
[TBL] [Abstract][Full Text] [Related]
11. Long-term quality-of-life evaluation after head and neck cancer treatment in a developing country.
Vartanian JG; Carvalho AL; Yueh B; Priante AV; de Melo RL; Correia LM; Köhler HF; Toyota J; Kowalski IS; Kowalski LP
Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1209-13. PubMed ID: 15492171
[TBL] [Abstract][Full Text] [Related]
12. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
[TBL] [Abstract][Full Text] [Related]
14. Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation.
Hanna E; Sherman A; Cash D; Adams D; Vural E; Fan CY; Suen JY
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):875-9. PubMed ID: 15262766
[TBL] [Abstract][Full Text] [Related]
15. Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.
Huang SH; O'Sullivan B; Xu W; Zhao H; Chen DD; Ringash J; Hope A; Razak A; Gilbert R; Irish J; Kim J; Dawson LA; Bayley A; Cho BC; Goldstein D; Gullane P; Yu E; Perez-Ordonez B; Weinreb I; Waldron J
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1078-85. PubMed ID: 24210079
[TBL] [Abstract][Full Text] [Related]
16. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
[TBL] [Abstract][Full Text] [Related]
17. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in head and neck cancer survivors: impact of pretreatment depressive symptoms.
Howren MB; Christensen AJ; Karnell LH; Funk GF
Health Psychol; 2010 Jan; 29(1):65-71. PubMed ID: 20063937
[TBL] [Abstract][Full Text] [Related]
19. [Preservation surgery of head and neck cancer. Results and postsurgical function].
Hirano M; Ohkubo H; Kurita S; Hirade Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):881-6. PubMed ID: 3389830
[TBL] [Abstract][Full Text] [Related]
20. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
